Demographic and clinical profiles of drug-induced psychosis: age, gender, and social context in a German cohort

Drug-induced psychosis (DIP) represents a complex clinical challenge, particularly among younger substance-using populations. Recent epidemiological data indicate increasing DIP prevalence and decreasing age at first presentation, underscoring its growing clinical and public health relevance. While DIP arises in the context of substance use, distinguishing transient episodes from emerging primary psychotic disorders remains difficult, and data on demographic and clinical variations are limited. We conducted a descriptive cohort study of 340 patients diagnosed with DIP (ICD-10: F1X.5) between 2010 and 2020 at two university hospitals in Germany. We collected data from all eligible cases (n = 170) from a toxicology department (Technical University of Munich, TUM), and from the same number of cases from a psychiatry department (Ludwig-Maximilians-Universität in Munich, LMU). Variables assessed included sociodemographic data, psychiatric symptoms, substance use (self-report and toxicology), comorbidities, and family history. Analyses included descriptive statistics, chi-square or Fisher’s exact tests, and Mann–Whitney U tests to examine group differences, and Cohen’s Kappa coefficients to quantify agreement between self-reported and toxicologically confirmed substance use. The cohort was predominantly male (77.4%) with a median age of 27 years. Migration background was present in 27.6%, with admissions peaking in 2015–2018. Psychotic symptoms were dominated by perceptual disturbances (62.3%) and thought disorder (76.3%). Women exhibited higher rates of tactile hallucinations, suicidal ideation, and depression (all p < 0.05) and tended to have higher serum ethanol levels. Daily substance use was common (69.0%), with polysubstance use exceeding 75%. Cannabis and stimulants predominated in younger patients, while opiates, sedatives, and ethanol were more frequent in older groups. Self-reported substance use showed fair to good agreement with toxicological findings, with the highest concordance for opiates and lower agreement for sedatives and ethanol. DIP showed clear gender- and age-related differences in psychotic symptom profiles and clinical presentation, alongside high rates of daily and polysubstance use, young male predominance, and migration-related patterns. These findings underscore the need for early, individualized, and demographically informed interventions.

Authors

Institutions

Publication Details

Journal
European Archives of Psychiatry and Clinical Neuroscience
Published
2026-03-31
DOI
https://doi.org/10.1007/s00406-026-02232-y
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Demographic and clinical profiles of drug-induced psychosis: age, gender, and social context in a German cohort

Stefanie Geith, Bernhard Haller, Gabriele Koller, Prof. Dr. Florian Eyer et al.
European Archives of Psychiatry and Clinical Neuroscience
Schizophrenia research and treatment
article

Demographic and clinical profiles of drug-induced psychosis: age, gender, and social context in a German cohort

Stefanie Geith, Bernhard Haller, Gabriele Koller, Prof. Dr. Florian Eyer, Nadia Böss, Kristina Adorjan
article en

Abstract

Drug-induced psychosis (DIP) represents a complex clinical challenge, particularly among younger substance-using populations. Recent epidemiological data indicate increasing DIP prevalence and decreasing age at first presentation, underscoring its growing clinical and public health relevance. While DIP arises in the context of substance use, distinguishing transient episodes from emerging primary psychotic disorders remains difficult, and data on demographic and clinical variations are limited. We conducted a descriptive cohort study of 340 patients diagnosed with DIP (ICD-10: F1X.5) between 2010 and 2020 at two university hospitals in Germany. We collected data from all eligible cases (n = 170) from a toxicology department (Technical University of Munich, TUM), and from the same number of cases from a psychiatry department (Ludwig-Maximilians-Universität in Munich, LMU). Variables assessed included sociodemographic data, psychiatric symptoms, substance use (self-report and toxicology), comorbidities, and family history. Analyses included descriptive statistics, chi-square or Fisher’s exact tests, and Mann–Whitney U tests to examine group differences, and Cohen’s Kappa coefficients to quantify agreement between self-reported and toxicologically confirmed substance use. The cohort was predominantly male (77.4%) with a median age of 27 years. Migration background was present in 27.6%, with admissions peaking in 2015–2018. Psychotic symptoms were dominated by perceptual disturbances (62.3%) and thought disorder (76.3%). Women exhibited higher rates of tactile hallucinations, suicidal ideation, and depression (all p < 0.05) and tended to have higher serum ethanol levels. Daily substance use was common (69.0%), with polysubstance use exceeding 75%. Cannabis and stimulants predominated in younger patients, while opiates, sedatives, and ethanol were more frequent in older groups. Self-reported substance use showed fair to good agreement with toxicological findings, with the highest concordance for opiates and lower agreement for sedatives and ethanol. DIP showed clear gender- and age-related differences in psychotic symptom profiles and clinical presentation, alongside high rates of daily and polysubstance use, young male predominance, and migration-related patterns. These findings underscore the need for early, individualized, and demographically informed interventions.

European Archives of Psychiatry and Clinical Neuroscience
TUM Klinikum (DE), LMU Klinikum (DE), Universitäre Psychiatrische Dienste Bern (CH), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE)
Technische Universität München
Gender equality
Openalex Percentile: Top 25%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.